Generate a tailored SOP for Dr. Paul Skehel. Improve your application with a focused, well-structured draft.
Paul Skehel is a Senior Lecturer at the University of Edinburgh, specializing in the role of VAP proteins in maintaining the function of the endoplasmic reticulum, particularly in the context of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). His research focuses on the mutations in the VAPB gene leading to ALS8, a form of motor neuron disease. Skehel's collaborative work aims to elucidate the molecular mechanisms by which VAP proteins operate within the secretory system and their interactions with various cellular pathways in neurodegeneration. He has a distinguished history of academic research, having previously worked with notable researchers and institutions, and has published extensively in his field, contributing to a better understanding of the pathways involved in neurodegeneration.
University of Edinburgh • Edinburgh
Research and teaching in the area of brain sciences with a focus on neurodegeneration.
National Institute for Medical Research • London
Worked under Dr. Tim Bliss in the Division of Neurophysiology.
Howard Hughes Medical Institute • New York
Collaborated with Prof. Eric Kandel in neurobiology.
Department of Marketing